2017/09/25

BIH Stem Cell Lecture: Validation of genomic variants as risk predictors of doxorubicin-induced cardiotoxicity using hiPSC

Prof. Paul Burridge, Center for Pharmacogenomics, Northwestern University Feinberg School of Medicine | Host: Sebastian Diecke, Organized by the Stem Cell Core Facility

The Burridge lab works in the field of pharmacogenomics and precision medicine, using human induced pluripotent cells (hiPSC) to study the role of the genome in drug response and complex disease traits. They aim to develop next generation tools for predicting which patients will experience adverse drug responses, validate the causal role of particular single nucleotide polymorphisms (SNPs), probe the mechanisms of action, and discover new drugs to overcome these complications.

 

The lecture will be held in English. / Die Vorlesung findet auf Englisch statt.